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Lupus Nephropathy S55antineutrophil cytoplasmic autoantibodies (ANCA) in assessing the prognosis
of refractory severe lupus nephritis (LN).
Methods: Eighty-four cases of refractory severe LN were randomly divided into
twogroupsof 42caseseach:CTXgroupandRTXgroup(CTX+RTX)duringFebruary
2010 to February 2014 in our hospital and First Affiliated Hospital of Zhengzhou
University. Changes in serum levels of anti-C1q antibodies and ANCA in the two
groups were examined, and efficacies of the drugs were compared.
Results: The total efficacy of RTX group was found to be 83.3 %, which was
significantly higher than that of the CTX group, 57.1 % (p< 0.05). The serum
anti-C1q antibodies and ANCA were decreased to 11.9% and 26.2 % in the
RTX-treated group, which was significantly lower than those observed in
the CTX-treated patients (21.4% and 69.0 % respectively) (p< 0.05). The
clinical indices of LN were significantly improved in the two groups after
the treatment. However, the urinary protein, albumin, complement C3,
the percentage of CD19+ B cells, and SLEDAI scores in the RTX group were
significantly lower than those in the CTX group (p< 0.05).
Conclusion: RTX plus CTX showed a better therapeutic efficacy compared to
single CTX, and it significantly improved the prognosis of refractory and se-
vere LN. Anti-C1q antibody and ANCA level may be valuable biomarkers for
the prognosis of LN.http://dx.doi.org/10.1016/j.hkjn.2015.08.143
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Low-dose Mycophenolate Mofetil in the Treatment of Lupus Nephritis
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Objective: To evaluate the efficacy of low-dose mycophenolate mofetil
(MMF) combined with low-dose prednisone in the treatment of lupus
nephritis.
Methods: Forty patients (5 males, 35 females) with lupus nephritis (10 in
class III, 18 in class IV, 12 in class V+IV) were treated with low-dose MMF
(1.0 g/d to 1.5 g/d) combined with prednisone 0.35 mg/(kg$d), course of
12 months, changes were observed before and after treatment in January,
March, June, September, December liver and kidney function, blood uric
acid, cholesterol, blood sugar, blood coagulation, urine, 24-hour urinary pro-
tein, serum antibody levels and other indicators.
Results: Complete remission in 28 patients (70%), partial remission in 8 pa-
tients (20%), and no relief in 4 patients (10), the total efficiency of 90%. Low-
doses of MMF combined with low-dose prednisone treatment of lupus
nephritis had no effect on liver function, creatinine, glucose, uric acid,
white blood cells, platelets. Treatment 1e3 months, plasma protein
increased, decreased 24-hour urinary protein, blood lipid levels decreased
(P< 0.05), 6e12 months after treatment significantly increased serum
albumi hemoglobin, and 24-hour urinary protein, blood lipid levels, serum
antibody levels were significantly decreased (P< 0.01). Only 1 case of infec-
tion occurred in 40 patients discontinued.
Conclusion: Low-dose MMF in combination with low-dose prednisone is
effective in treating lupus nephritis, has better treatment safety, and low
incidence of infection.http://dx.doi.org/10.1016/j.hkjn.2015.08.144
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Objectives: To investigate the utility of diffusion weighted imaging (DWI)
and blood oxygen level-dependent (BOLD) MR imaging in the assessment ofrenal hypoxia in an experimental model of mice with established lupus
nephritis (LN).
Methods: Sixteen-week-old female MRL/lpr mice (n Z 13) were studied
and 14 week old male C57BL/6 mice (n Z 10) served as controls. The
mice underwent coronal echo-planar DWI and BOLD MR imaging of the
kidneys. Hypoxyprobe was administed intraperitoneally to the mice 1
hour before they were sacrificed. The distribution of HypoxyprobeTM-1,
hypoxia-inducible factor 1a (HIF-1a) and heme oxygenase-1 (HO-1) in
renal tissues were detected by immunohistochemical analyses and West-
ern blot. The apparent diffusion coefficient (ADC) and R2* value of the
kidneys was calculated with b values of 0 and 500 s/mm2. The relation be-
tween the renal hypoxia parameters and the ADCs or R2* values were
evaluated.
Results: Glomerular mesangial proliferation and basement membrane
thickening, tubular epithelial cells damage, interstitial leukocytes infiltra-
tion, especially the large accumulation of inflammatory cells surrounding
small vessels were observed in MRL/lpr mice. It was found that Hypoxypro-
beTM-1, HIF-1a and HO-1 distributed widely in the renal tissues of MRL/lpr
mice, and closely associated with the renal tubulointerstitial lesions. The
mean ADC values of kidneys in MRL/lpr mice were 1.52  0.27 x 10－
3 mm2/s, the mean R2* values of the renal cortex and medulla were
30.95  4.59/sec and 23.43  3.06/sec respectively, which were all signif-
icantly lower than that in C57BL/6 mice (p Z 0.037, p Z 0.03 and
pZ 0.043, respectively). The mean R2* values were negatively correlated
with the degree of tubulointerstitial lesions and the expression of hypoxia
parameters.
Conclusion: The results suggested that renal hypoxia is one of the key fac-
tors leading to renal tubulointerstitial lesion, and functional MRI may used to
monitor renal hypoxia in LN.
*Funding was provided by the National Natural Science Foundation of China
(81170671).http://dx.doi.org/10.1016/j.hkjn.2015.08.145
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Objective: Early diagnosis is important for the outcome of lupus nephritis
(LN). But the pathological type of LN is closely related to the clinical man-
ifestations, and hence the treatment of LN depends on different patholog-
ical types. To assess the level of monocyte chemotactic protein (MCP-1),
fractalkine (Fkn), and receptor for advanced glycation end product
(RAGE) in different pathological types of lupus nephritis and to explore
the value of these biomarkers in predicting the prognosis of lupus
nephritis.
Methods: In the patients included in this study, through renal biopsy, class III
and class IV were defined as proliferative group, class V as nonproliferative
group, class V+III and class V+IV as mixed group. During the follow-up, 40 of
the 178 enrolled patients were found to have poor response to standard
immunosuppressant therapy. The level of markers in the different response
groups was tested.
Results: The levels of urine and serum MCP-1, urine and serum Fkn, and
serum RAGE were higher in the proliferative group, and lower in the nonpro-
liferative group, and the difference was significant. The levels of urine and
serum MCP-1 and serum RAGE were lower in the poor response group; the
difference was also significant. The relationship between urine MCP-1, urine
and serum Fkn with the Systemic Lupus Erythematosus Disease Activity Index
was proved.
Conclusion: The concentration of cytokines MCP-1, Fkn, and RAGE may be
correlated with the nuclear factor-kappaB pathway. The urine and serum
MCP-1 and serum RAGE may help in predicting the prognosis before standard
immunosuppressant therapy.
